Biomarker Correlates of Clinical Outcomes from a Global phase 1b Study of JNJ-90014496, CD20/CD19 Bi-Specific Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Large B-cell Lymphoma (LBCL)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Mahipal V. Suraneni, Da Yin, Dianna Wu, Daksh Thaper, Shajo Kunnath-Velayudhan, Jianmei Wu, Alfredo Perales‐Puchalt, Melissa Jo Beelen, Julie S. Larsen, Leen Slaets, Arnob Banerjee, Donne Bennett Caces
+8 more Jacqueline Bussolari, Luke J. Mountjoy, Joanna Meehan Rhodes, Jacob Haaber, Martin Hutchings, Matthew Ku, Krish Patel, Vicki Plaks
DOI: 10.1016/j.jtct.2025.12.225
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Lymphoma Diagnosis and Treatment T-cell and B-cell Immunology

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S165–S165
Publication date
1 February 2026
Language
EN